• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Davis+Gilbert LLP

From our base in New York, we represent a diverse range of clients across the country and around the world.

  • People
  • Services
  • Emerging Issues

health claims

FTC and FDA Sent Warning Letters to Companies Advertising Products that Claim Treatment of Disease

March 7, 2019 by Megan O'Malley

The Bottom Line The FTC and FDA are aggressively reviewing companies’ websites and social media channels for false or unsubstantiated health claims and efficacy claims. Advertisements on company websites and in social media posts must avoid false or unsubstantiated health claims, and efficacy Continue Reading

Alert - March 7, 2019

Primary Sidebar

  • Sitemap
  • Privacy Policy
  • Terms and Conditions
  • About Us
  • Subscribe
  • Location
© 2023 Copyright Davis+Gilbert LLP. Attorney Advertising.
  • People
  • Services
  • Emerging Issues
  • Insights + Events
  • Diversity, Equity + Inclusion
  • Pro Bono + Corporate Social Responsibility
  • Careers
  • About Us
  • Subscribe
  • Location